Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

(MedPage Today) -- CHICAGO -- An investigational individualized vaccine for surgically resected melanoma demonstrated durable benefits in reducing the risks of recurrence and distant spread, 5-year follow-up of a randomized study showed. Adding...
Source
MedPage Today
Opens original article in a new tab



